JEE Main 2021: Admit cards for February session to be released next week; check jeemain.nta.nic.in

-

The admit cards for the February session of Joint Entrance Examination (JEE) Main 2021 are likely to be released next week online. The National Testing Agency (NTA) is responsible for conducting the national-level entrance exams and NTA will release the hall tickets on its official website soon.

As per an official notification, NTA is scheduled to release the hall ticket for JEE Main 2021 February session in the second week of February. A report by Times Now suggests the tentative date of the release of admit cards is 10 February, 2021.

Candidates set to appear in the engineering entrance exam are advised to visit jeemain.nta.nic.in regularly to stay updated. No personal intimation is going to be sent to the applicants.

The hall ticket is likely to carry several important details about the exam. The admit card is going to have the name of the examination centre, slot assigned to a particular candidate and the reporting time.

Once the link gets activated, follow these steps to download the JEE Mains 2021 admit card:

Step 1: Visit the official site of NTA JEE at jeemain.nta.nic.in
Step 2: Click on the link that says: ‘JEE Main admit card 2021’ on the homepage
Step 3: You will be redirected to another page
Step 4: Enter your login credentials in the given space (your application number and password/ date of birth)
Step 5: Once you have logged in, your hall ticket will appear on the screen
Step 6: View the admit card, download the document and take a print out for future use

According to NDTV, candidates seeking admission into National Institutes of Technology (NITs), Indian Institutes of Information Technology (IIITs), and other centrally funded technical institutes need to sit in the JEE Main exam and pass the written computer-based test.

This year, Dr APJ Abdul Kalam Technical University (AKTU), Lucknow will also admit students on the basis of their JEE results.



from Firstpost India Latest News https://ift.tt/39UqcHK
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more